Use Nektar Therapeutics performance together with your assets to protect against small markets fluctuations as well as to check it against diversification policy that fits your risk preferences.
If you would invest 787 in Nektar Therapeutics on April 26, 2012 and sell it today you would lose (91.00) from holding Nektar Therapeutics or give up 11.56% of portfolio value over 30 days. Nektar Therapeutics is currenly does not generate positive expected returns and assumes 2.81% risk (volatility on return distribution) over the 30 days horizon. In different words, 47% of equities are less volatile than Nektar Therapeutics and 99% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
Daily Expected Return (%)
Risk [Daily Volatility] (%)
Given investment horizon of 30 days, Nektar Therapeutics is expected to under-perform the market. In addition to that, the company is 3.85 times more volatile than its market benchmark. It trades about -0.17 of its total potential returns per unit of risk. The NYSE is currently generating roughly -0.47 per unit of volatility.
Nektar Operating Margin
Based on recorded statements Nektar Therapeutics has Operating Margin of -161.69%. This is 488.18% higher than that of Healthcare sector, and 91.67% higher than that of Biotechnology industry, The Operating Margin for all stocks is 3051.85% higher than the company.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.
Over the last 30 days Nektar Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions.
1 Month Effecincy (a.k Sharpe Ratio) ...
-0.17
BestPortfolio
BestEquity
Good Returns
Average Returns
Small Returns
Cash
SmallRisk
AverageRisk
HighRisk
HugeRisk
Negative Returns
NKTR
Estimated Market Risk
2.81
actual daily
53 %
of total potential
Expected Return
-0.49
actual daily
1 %
of total potential
Risk-Adjusted Return
-0.17
actual daily
1 %
of total potential
Based on monthly moving average Nektar is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nektar by adding it to a well-diversified portfolio.
Follow Nektar Performance with your standard RSS feed, custom widget, or your favorite social app
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
